Ionic liquids are well known and frequently used 'designer solvents' for biocatalytic reactions. This review highlights recent achievements in the field of multiphasic ionic liquid-based reaction concepts. It covers classical biphasic systems including supported ionic liquid phases, thermo-regulated multi-component solvent systems (TMS) and polymerized ionic liquids. These powerful concepts combine unique reaction conditions with a high potential for future applications on a laboratory and industrial scale. The presence of a multiphasic system simplifies downstream processing due to the distribution of the catalyst and reactants in different phases.
Introduction
Within the last decades, biocatalysts became a very powerful alternative to classical chemical and chemical reaction systems (Nestl et al. 2011; Reetz 2013 ). This includes their use from laboratory up to large-scale applications for the synthesis of bulk chemicals, fine chemicals and agrochemicals (Wenda et al. 2011; Patel 2011; Busacca et al. 2011) . Major examples comprise the synthesis of bio-based compounds such as (bio)ethanol, acrylamide, antibiotics and various intermediates for active pharmaceutical ingredients (APIs) (Muñoz Solano et al. 2012) . Herein biocatalysts, applied either as isolated enzymes or whole microbial cells, offer significant advantages, e.g. mild reaction conditions, high regio-and enantio-selectivities and a general use of water as solvent. The increasing demand for new bioactive molecules and bio-based products continues to fuel the search for new biocatalysts for the use in synthetic pathways (Renata et al. 2015; Bornscheuer et al. 2012) . Already existing biocatalysts can be further improved by protein engineering techniques to adjust certain features such as substrate range (Turner 2003) , selectivity (Luetz et al. 2008) , solvent compatibility (Reetz 2003) , and process stability (Singh et al. 2013) . Consequently, biocatalysts are frequently used to enable alternative and more eco-friendly synthetic pathways, which also include an integrated use with classical chemical and catalytic reaction systems (Wohlgemuth 2010) .
However, enzymes usually operate best in aqueous media because of their native origin in prokaryotic or eukaryotic cells. Nevertheless, there are various successful examples of biocatalysis in or with organic solvents (Stepankova et al. 2013) . These reactions are frequently carried out in twophase systems consisting of organic solvents and water. Here, the organic phase is often used as a substrate and product reservoir (if the main reactants are only sparingly soluble in water), whereas the aqueous phase contains and stabilizes the enzyme by retaining its hydration shell (Hernández Fernández et al. 2015) . In addition, the product can be recovered from the organic layer. The stability of biocatalysts in such classical non-aqueous environments is unfortunately often limited, which pathed the success of ionic liquids (ILs) as substitutes for molecules solvents or volatile organic compounds (VOCs) (Kragl et al. 2002; Sheldon et al. 2002; Oppermann et al. 2011; Zhao and Baker 2013; Sheldon 2014 Sheldon , 2016 Stein and Kragl 2014; Sivapragasam et al. 2016; Itoh 2017) .
Since the late 1990s ILs have become a major research topic and the number of scientific publications about these relatively new class of compounds has risen almost exponentially (Itoh 2017; Sivapragasam et al. 2016; Zhao et al. 2013; Sheldon et al. 2002; Kragl et al. 2002; Hallett and Welton 2011) . Here ILs are in general characterized as salt-based compounds that include (typically) one cation and one anion with a melting point considerably below 100°C. Such a low melting point is based on low coulomb-, van-der Waals-and hydrogen bond-interactions (Olivier-Bourbigou et al. 2010) . The unique composition of ILs facilitate interesting miscibilities with classical molecular solvents, typically high solubilities of unpolar compounds, low vapor pressure, high ionic conductivity and a general non-flammable nature. Most ILs are based on organic cations in combination with anions with a strongly delocalized negative charge (see below). This highly tunable chemical composition allows high thermal and chemical stability. Various enzymatic reactions in, or strictly speaking in the presence of, ILs were reported in scientific literature (Naushad et al. 2012; Zhao 2010; Moniruzzaman et al. 2010) . There is also a large number of reviews covering various aspects over the years (Kragl et al. 2002; Sheldon et al. 2002; Zhao and Baker 2013; Benedetto and Ballone 2016a, b; Sivapragasam et al. 2016; Itoh 2017) . Within this short review, we will cover recent developments in the use of ionic liquid in multiphasic solvent systems, which allow the design of specialized biocatalytic reaction concepts.
Biocatalysis with ionic liquids

Biphasic reaction systems
Downstream processing (e.g. separation of products, recovery of the biocatalyst or preferably recycling of reaction streams) is a major challenge in various biotechnological processes. Due to the growing demand for biotechnologically manufactured fine chemicals and biomolecules, this topic was focused on in recent years (Oppermann et al. 2011) . Successful examples of the utilization of biphasic reaction systems with ILs are described in the following.
The biphasic reaction systems considered in this review are mostly composed of an IL and a buffer solution. To form such a two-phase system, both applied liquids need to be in equilibrium with each other and only partially miscible in the given proportions. The solution phase behaviour of such partially miscible mixtures can be described by a binary phase diagram (see Fig. 1 ). The binodal (coexistence curve) divides the phase diagram into a homogeneous and a heterogeneous region (miscibility gap), thus representing exactly the line of coexistence of both phases. Changing the temperature can shift the balance of the liquid-liquid equilibrium (LLE) to one side or the other. The most common types of miscibility gaps include systems with upper critical solution temperature (UCST) and systems with lower critical solution temperature (LCST). At temperatures above UCST, the system is completely miscible in all proportions, whereas below UCST partial miscibility of the liquids occurs. At temperatures below LCST, the system is completely miscible in all proportions, whereas above LCST partial miscibility of the liquids occurs. At a given temperature and pressure, phase separation occurs if a mixture (e.g. red point in Fig. 1 ) is located in the biphasic region of a phase diagram. The resulting two phases have different compositions x1 and x2 (red dotted lines). Although the description of IL-based twophase system as a binary mixture is sufficient for most applications, the exact description of phase systems is a more complicated matter. Correctly, each component in the mixtures needs to be considered (e.g. buffer salts or other components), resulting in ternary or even higher mixtures, etc., as discussed in detail elsewhere (Gutowski et al. 2003; Freire et al. 2012; Bridges et al. 2007; Behr et al. 2011) .
Over the past years, primarily [PF 6 ] anions were used for biphasic IL-based reaction systems. The basic structures are shown in Fig. 2 . The secondary, immiscible solvent forming the intended two-phase system is usually water, but also IL-organic solvent-based systems were reported (Hou et al. 2017) . However, the number of water nonmiscible ionic liquids is still limited and the majority of the systems is widely miscible with water. (Wood et al. 2011) In Table 1 , a number of different systems published recently are listed covering different types of biphasic reaction systems. Besides the two-phase system, the reaction and a brief comment are given. The IL phase is generally designed to solubilize the desired non-polar substrates and products. The second solvent then contains the biocatalytic reaction system (entries 1-15). This includes the use as whole cell biocatalysts and (partly) purified enzymes in free or immobilized form. However, recent investigations include the use of reactioninduced phase changes (entry 16) and supported IL phases (entries 17-18). In addition, recent studies also investigated the influence of such a biphasic reaction systems on whole cell systems (entries 19-20).
As mentioned above, biphasic reaction systems are herein mainly applied for poorly water soluble, unpolar substrates and products, wherein the IL phase represents the substrate reservoir and in situ-extractant for the product, which also simplifies downstream processing. In addition, the high hydrophobicity of the ILs may also prevent negative effects to the catalytic system, e.g. invasive effects on cellular membranes. For example, Zhang et al. reported the use of various hydrophobic ILs in a biphasic reaction system for the conversion of ATMS ( a c e t y l t r i m e t h y l s i l a n e ) t o ( R ) -1 -T M S E ( ( R ) -1 -trimethylsilylethanol) ( Fig. 3; Table 1 , entry 11).
Both reactants are highly toxic to the used whole cell biocatalyst and the authors investigated various water-immiscible ILs to overcome this limitation, resulting in 1-butyl-3-methylimidazolium hexafluorophosphate [BMIM] [PF 6 ]/buffer biphasic system providing optimal conditions. Significantly higher reactant concentration with a high operational stability was found. The immobilized cells retain their high activity in the biphasic system and the presented reaction system was eventually applied at preparative scale with > 90 yield and > 99% e.e.
(R).
A different approach with a non-aqueous biphasic reaction system was recently presented by Sandig et al. in (Fig. 4) . This concept basically represents a supported IL phase (SILP) for CalB, while an external solvent (in this case MTBE) is used as a continuous phase that contains all required reactants. The experimental setup was continuously operated in a 0.46 × 15 cm column at 50°C achieving a productivity of 58 mmol mg −1 (CalB) min
, which corresponds in this experiment to a total turnover number (TON) of 3.9 × 10 7 . A product-based-induced phase change during the reaction was evaluated in detail by Devi et al. for the enzymatic methanolysis of rapeseed oil (transesterification) ( Fig. 5 ; Table 1 , entry 16) to produce fatty acid methyl ester (FAME, biodiesel). This reaction system facilitates 98% biodiesel yield in combination with a simplified downstream processing via phase separation.
In this study, the authors investigated 24 commercially available ILs with different cations and anions and evaluated the reaction characteristics and phase behaviour. Finally, they selected the most promising candidates Ammoneng 102 and Ammoeng 120. This reaction system shows the unique property to spontaneously separate into immiscible phases during the reaction. The formation of mono-and diglycerides initially yields an intermittent ternary phase system with an oil phase, mesophase and IL phase. After completion of the reaction, the reaction system separates into a binary phase system of an oil phase (FAME) and IL phase (MeOH, glycerol and IL), which simplifies downstream processing to a large extent.
Thermo-regulated multi-component solvent systems
In contrast to classical biphasic systems, thermo-regulated multi-component systems facilitate a temperature-induced phase change, which is based on the corresponding phase diagram (see Fig. 1 ). By a change of temperature, the reaction systems can be switched between a one-and two-phase system. Such systems are also called thermomorphic systems. For example, Mai et al. have developed such a temperatureregulated two-phase system composed of amino acid-based IL and water (LCST-type, see above) (Mai and Koo 2014) . The system was used for an enzymatic in situ penicillin G hydrolysis (see Scheme 1) and product separation. In a phosphate buffer with 30 wt% IL (tetra-n-butylphosphonium trifluoromethanesulfonylleucine, [TBP] [Tf-Leu], the reaction was carried out at 37°C with a hydrolysis yield of 87.1%. After reaction, the system was heated to 42°C and a phase separation occurred. The ILs could be reused for at least five cycles without significant loss in hydrolysis efficiency when fresh enzyme was added.
Lozano et al. used a similar reaction system with t h e I L 1 -m e t h y l -3 -o c t a d e c y l i m i d a z o l i u m bis(trifluoromethylsulfonyl)imide [C 18 MIM] [
NTf 2 ] and the biocatalyst Novozym 435 for the methanolysis of triolein to produce biodiesel (Fig. 6) (Lozano et al. 2010) .
The reaction including the downstream processing pathway is shown in Fig. 7 . The initial reaction was initiated by addition of triolein and methanol to [C 18 MIM][NTf 2 ]. The system was subsequently heated to 60°C and became monophasic due to its UCST-type behaviour. Afterwards, Novozym 435 was added to initiate the reaction (step 1, Fig. 7 ) and after the reaction, water was added at 50°C to extract methanol and glycerol, resulting in a two-phase system (step 2, Fig. 7 ). After cooling, the aqueous phase was removed and, as a second extraction step, octane was added to the remaining solid IL phase. After heating to 50°C, the biodiesel (methyl oleate) was extracted (step 3, Fig. 7 ) at 30°C. Finally, the residual IL layer was dried under a vacuum to remove traces of octane. A new process cycle was started by adding methanol and triolein and at least seven runs were performed, and no loss of activity of biocatalytic reaction was observed. Fig. 8 ) (Lozano et al. 2012) . The reactions were carried out in temperatureswitchable IL/solid phases system leading to easy product recovery. Sixteen different flavor esters were synthesized via this approach.
For the direct esterification reaction, the desired alcohol and carboxylic acid were added as a second phase to solid (Fig. 9) . The reaction was started by adding Novozym 435 and subsequent heating to 50°C resulting in a monophasic and fully clear reaction solution. After 14 h, the reaction mixtures were cooled and consecutively centrifuged four times at room temperature, 21, 10 and 4°C, resulting in a bottom solid phase containing IL and immobilized enzyme and a clear top IL-free liquid phase containing products and non-reacted substrates. The flavor ester and the non-reacted substrates were decanted and the remaining IL/enzyme solid phase was conditioned under a vacuum to remove any remaining product/substrate traces. By adding a new liquid phase of alcohol and carboxylic acid, a new process cycle can be initiated at least for seven times. Product yields up to > 99% were achieved. Unfortunately, a scale up of the whole reaction protocol to produce several grams or even kilograms was not shown in the study.
Further (Lozano et al. 2014) , and the biocatalytic synthesis of monoacylglycerides by the direct esterification of fatty acids with glycerol in different ILs (Lozano et al. 2017) . 
Polymerized ionic liquids
In contrast to classical biphasic systems, recently, a novel catalytic concept involving cross-linked ILs in gel-like compositions was reported in literature (Claus et al. 2018) . Herein typically free radical polymerization of vinyl groups at the cation of the IL is polymerized, e.g. 1-vinyl-3-ethylimidazolium together with a cross-linker, which creates a three-dimensional network and consequently encapsulates in some form the corresponding biocatalyst. Usually, additional surfactants are preferred to generate a microencapsulation before curing and thus solidifying the IL to an IL-polymer-gel, which is typically referred to as polymerized ILs (PILs) (Fig. 10) . This concept was used for the encapsulation of Candida rugose lipase by Moniruzzaman et al. (2012) , horseradish peroxidase by Nakashima et al. (2009) and glucose oxidase by Sánchez-Paniagua López et al. (2006) .
Generally, slightly lower activities were found with these enzyme preparations, which seems to originate mainly from the entrapment procedure. The presence of free radicals during the radical polymerization might affect the encapsulated enzyme, and the formed polymer layer around the biocatalyst will eventually cause some kind of diffusion limitation.
We have recently immobilized raw extract of CaLB in hydrogels based on [VEIm] [Br] and compared in the kinetic resolution of 1-phenylethanol with commercially available immobilisates such as Novozym 435 (Grollmisch et al. submitted) . 
Conclusions
The use of ILs is a powerful alternative to classical organic solvents in biocatalysis and thus avoids the use of hazardous compounds. In this review, we summarize the use of ILs in multiphasic IL-based systems such as classical biphasic solvent systems (liquid-liquid), thermo-regulated multi-component solvent systems (temperature-induced phase changes) and polymerized ILs (solid-liquid). An overview of recent developments in the use of ILs-solvent mixtures with respect to a defined biocatalytic reaction has been presented in detail. However, it should be kept in mind that the interaction of ILs especially with proteins is better described using the Hofmeister series rather than treating the IL similar to a molecular solvent and using octanol-water distribution coefficients respectively the logP-concept (Yang 2009 ).
Due to the ionic structure within the huge group of ILs, these reaction concepts facilitate unique conditions with a high potential for future applications on a laboratory and industrial scale. This primarily includes their use for the design of very stable biocatalyst preparations in combination with a simplified downstream processing due to the presence of phase boundary. Examples are applications in biodiesel and flavor ester synthesis. Typical transfer limitations can be also overcome by the use of supported IL phases, which combine the classical advantages of biocatalyst immobilization with the advantageous properties of ILs.
Future research will most likely concentrate on further developments of polymerized ILs and specifically tailor-made ILs for existing processes to enhance productivity and atom efficiency of biocatalytic reactions. In addition, concept to recycle and re-use ILs should be developed to improve the commercial applicability of the shown ILs. Herein multiphasic approaches, e.g. by using water-immiscible ILs, will be preferred. Conflict of interest Lars-Erik Meyer declares that he has no conflict of interest. Jan von Langermann declares that he has no conflict of interest. Udo Kragl declares that he has no conflict of interest.
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